Vor Biopharma Inc.

$15.55+10.05%(+$1.42)
TickerSpark Score
55/100
Mixed
100
Valuation
40
Profitability
15
Growth
68
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VOR research report →

52-Week Range20% of range
Low $3.30
Current $15.55
High $65.80

Companywww.vorbio.com

Vor Biopharma, Inc. , a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies.

CEO
Jean-Paul Kress
IPO
2021
Employees
159
HQ
Cambridge, MA, US

Price Chart

+335.57% · this period
$53.40$28.43$3.47May 20Nov 18May 20

Valuation

Market Cap
$106.58M
P/E
-0.01
P/S
0.00
P/B
-0.04
EV/EBITDA
0.05
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
87.31%
ROIC
-76.08%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-695,981,000 · -495.29%
EPS
$-70.50 · -107.35%
Op Income
$-371,642,000
FCF YoY
-43.81%

Performance & Tape

52W High
$65.80
52W Low
$3.30
50D MA
$14.98
200D MA
$20.73
Beta
1.75
Avg Volume
1.03M

Get TickerSpark's AI analysis on VOR

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Apr 22, 26RA CAPITAL MANAGEMENT, L.P.sell165,150
Apr 17, 26RA CAPITAL MANAGEMENT, L.P.sell458,411
Apr 20, 26RA CAPITAL MANAGEMENT, L.P.sell171,963
Apr 13, 26RA CAPITAL MANAGEMENT, L.P.sell530,610
Apr 14, 26RA CAPITAL MANAGEMENT, L.P.sell153,735
Apr 15, 26RA CAPITAL MANAGEMENT, L.P.sell53,644
Apr 8, 26RA CAPITAL MANAGEMENT, L.P.sell353,242
Apr 8, 26RA CAPITAL MANAGEMENT, L.P.sell130,862
Apr 9, 26RA CAPITAL MANAGEMENT, L.P.sell135,201
Apr 10, 26RA CAPITAL MANAGEMENT, L.P.sell828

Our VOR Coverage

We haven't published any research on VOR yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate VOR Report →

Similar Companies